Brazil Xience V Everolimus-Eluting Coronary Stent System "Real-World" Outcomes Registry (BRAVO)

Cardiovascular Research Center, Brazil

Status: Completed

Conditions: Arterial Coronary Disease

Study type: Observational

Funder types: Other

Identifiers

NCT00989066

BRA01

Details and patient eligibility

About

To evaluate the performance and long-term clinical outcomes of the Xience V everolimus-eluting coronary stent system (EECSS) in the treatment of minimally selective, high risk patients in the real-world clinical practice.

Full description

Prospective, multicenter, non-randomized, post-marketing web-based registry.Patients all comers assigned for percutaneous coronary intervention (PCI) who present with at least one angiographically documented coronary artery lesion suitable for percutaneous treatment with implantation of Xience V EECSS only can be included on this Registry.

Enrollment: 535 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients >18 years of age; clinical indication for elective or emergency PCI with stent implantation of at least one angiographically documented coronary artery lesion; agreement to undergo ALL study protocol follow-ups
• Diseased coronary vessel(s) with the presence of at least one obstruction >50% diameter stenosis by visual estimation in a major epicardial vessel or a major branch (≥2.50mm), with anatomy suitable for percutaneous treatment with implantation of the Xience V EECSS

Exclusion criteria

• Known illness with life expectancy <24 months; impossibility to comply with all protocol follow-ups
• Coronary anatomy unsuitable for percutaneous treatment with implantation of the Xience V EECSS